107 related articles for article (PubMed ID: 2433360)
1. Interferon-induced phenotypic changes in human tumor cells relative to the effects of interferon on c-ras oncogene expression.
Brouty-Boyé D; Wybier-Franqui J; Nardeux P; Daya-Grosjean L; Andeol Y; Suarez HG
J Interferon Res; 1986 Oct; 6(5):461-71. PubMed ID: 2433360
[TBL] [Abstract][Full Text] [Related]
2. Interferon-induced modulation of human ras oncogene expression.
Samid D; Schaff Z; Chang EH; Friedman RM
Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
[TBL] [Abstract][Full Text] [Related]
3. Interferon-mediated regulation of myc and Ki-ras oncogene expression in long-term-treated murine viral transformed cells.
Emanoil-Ravier R; Pochart F; Canivet M; Garcette M; Tobaly-Tapiero J; Peries J
J Interferon Res; 1985; 5(4):613-9. PubMed ID: 2418130
[TBL] [Abstract][Full Text] [Related]
4. Development of transformed phenotype induced by a human ras oncogene is inhibited by interferon.
Samid D; Chang EH; Friedman RM
Biochem Biophys Res Commun; 1985 Jan; 126(1):509-16. PubMed ID: 3970704
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma induces altered oncogene expression and terminal differentiation in A431 cells.
Chang EH; Ridge J; Black R; Zou ZQ; Masnyk T; Noguchi P; Harford JB
Proc Soc Exp Biol Med; 1987 Dec; 186(3):319-26. PubMed ID: 3122220
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment of human carcinoma cells with interferon alpha.
Brouty-Boyé D; Mogensen KE; Gresser I
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):507-14. PubMed ID: 4040023
[TBL] [Abstract][Full Text] [Related]
9. Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene.
Samid D; Chang EH; Friedman RM
Biochem Biophys Res Commun; 1984 Feb; 119(1):21-8. PubMed ID: 6200112
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effects of interferons against human bladder carcinoma cell lines in vitro.
Grups JW; Frohmüller HG
Urol Int; 1988; 43(5):265-8. PubMed ID: 2462294
[TBL] [Abstract][Full Text] [Related]
12. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
Rimoldi D; Samid D; Flessate DM; Friedman RM
Cancer Res; 1988 Sep; 48(18):5157-62. PubMed ID: 2457435
[TBL] [Abstract][Full Text] [Related]
14. Consequences of altered oncogene expression in rodent cells.
Pragnell IB; Spandidos DA; Wilkie NM
Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):107-19. PubMed ID: 2866518
[TBL] [Abstract][Full Text] [Related]
15. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
[TBL] [Abstract][Full Text] [Related]
16. A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line.
Nardeux PC; Daya-Grosjean L; Landin RM; Andéol Y; Suàrez HG
Biochem Biophys Res Commun; 1987 Jul; 146(2):395-402. PubMed ID: 3476115
[TBL] [Abstract][Full Text] [Related]
17. Cytocidal effect of purified human fibroblast interferon on tumor cells in vitro.
Ito M; Buffett RF
J Natl Cancer Inst; 1981 May; 66(5):819-25. PubMed ID: 6164812
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
19. The effects of interferon on the expression of human papillomavirus oncogenes.
Kim KY; Blatt L; Taylor MW
J Gen Virol; 2000 Mar; 81(Pt 3):695-700. PubMed ID: 10675406
[TBL] [Abstract][Full Text] [Related]
20. Human oncogenes detected by a defined medium culture assay.
Zhan X; Culpepper A; Reddy M; Loveless J; Goldfarb M
Oncogene; 1987; 1(4):369-76. PubMed ID: 3330780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
